ES8501628A1 - Procedimiento para la fabricacion de nuevos productos a partir del factor timico del suero, de sus analogos y derivados. - Google Patents
Procedimiento para la fabricacion de nuevos productos a partir del factor timico del suero, de sus analogos y derivados.Info
- Publication number
- ES8501628A1 ES8501628A1 ES518298A ES518298A ES8501628A1 ES 8501628 A1 ES8501628 A1 ES 8501628A1 ES 518298 A ES518298 A ES 518298A ES 518298 A ES518298 A ES 518298A ES 8501628 A1 ES8501628 A1 ES 8501628A1
- Authority
- ES
- Spain
- Prior art keywords
- products
- derivatives
- radioactive tracers
- thymic
- tsf
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 238000000034 method Methods 0.000 title abstract 4
- 230000002992 thymic effect Effects 0.000 title abstract 3
- 239000000700 radioactive tracer Substances 0.000 title 2
- 229940079593 drug Drugs 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 239000002184 metal Substances 0.000 abstract 6
- 150000004696 coordination complex Chemical class 0.000 abstract 2
- 102000004169 proteins and genes Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 239000000126 substance Substances 0.000 abstract 2
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6863—Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
- C07K7/062—Serum thymic factor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Cell Biology (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- Microbiology (AREA)
- Genetics & Genomics (AREA)
- Food Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
PROCEDIMIENTO PARA LA FABRICACION DE NUEVOS PRODUCTOS A PARTIR DEL FACTOR TIMICO DEL SUERO, DE SUS ANALOGOS Y DERIVADOS.CONSISTE EN TRATAR EL FACTOR TIMICO DEL SUERO O UNO DE SUS ANALOGOS O DERIVADOS CON UN METAL BIVALENTE O TRIVALENTE COMO ZINC, O CON UNA SUSTANCIA PROTEICA QUE ES UNA FRACCION DE EXTRACTO TIMICO, PREPARANDO A CONTINUACION UN TRAZADOR QUE COMPRENDE EL PRODUCTO MARCADO POR UN ISOTOPO RADIOACTIVO MEDIANTE LA INTRODUCCION PREVIA DE UNA MOLECULA YODABLE PARA EL PRODUCTO, PROCEDIENDO LUEGO AL YODADO DEL DERIVADO YODABLE CONSEGUIDO. EL FACTOR DE ACIDEZ ESTA COMPRENDIDO ENTRE 7 Y 9 DURANTE 10 A 30 MINUTOS Y A TEMPERATURA AMBIENTE, UTILIZANDOSE UNA PORCION DE UN MOL DE FACTOR FTS POR CADA 0,1 A 10 MOLES DE METAL O DE UNA DE SUS SALES.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8017027 | 1980-05-22 | ||
| GB8030507 | 1980-09-22 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| ES8501628A1 true ES8501628A1 (es) | 1984-12-16 |
| ES518298A0 ES518298A0 (es) | 1984-12-16 |
Family
ID=26275622
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES502911A Expired ES8306022A1 (es) | 1980-05-22 | 1981-05-22 | Procedimiento para la preparacion de productos derivados delfactor timico del suero (fts),de sus analogos y derivados |
| ES518298A Granted ES518298A0 (es) | 1980-05-22 | 1982-12-16 | Procedimiento para la fabricacion de nuevos productos a partir del factor timico del suero, de sus analogos y derivados. |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES502911A Expired ES8306022A1 (es) | 1980-05-22 | 1981-05-22 | Procedimiento para la preparacion de productos derivados delfactor timico del suero (fts),de sus analogos y derivados |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP0041019B1 (es) |
| AU (1) | AU553640B2 (es) |
| CA (1) | CA1170991A (es) |
| DE (1) | DE3166925D1 (es) |
| DK (1) | DK221681A (es) |
| ES (2) | ES8306022A1 (es) |
| GR (1) | GR75636B (es) |
| IE (1) | IE51744B1 (es) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4634682A (en) * | 1982-11-30 | 1987-01-06 | Sloan-Kettering Institute For Cancer | Radioimmunoassays for the serum thymic factor (FTS) |
| CS256897B1 (en) * | 1984-12-17 | 1988-04-15 | Evzen Kasafirek | Series thymic factor's analogue-type peptides |
| IT1188550B (it) * | 1986-02-07 | 1988-01-14 | Sclavo Spa | Peptide sintetico ad attivita' interleukina 1 umana |
| FR2830451B1 (fr) * | 2001-10-09 | 2004-04-30 | Inst Nat Sante Rech Med | Utilisation de peptides analogues de la thymuline(pat)pour la fabrication de medicaments contre la douleur |
| EP2007318B8 (en) | 2006-03-20 | 2014-03-12 | Smith & Nephew, Inc. | Acetabular cup assembly for multiple bearing materials |
| FR2930156B1 (fr) * | 2008-04-21 | 2011-10-28 | Cll Pharma | Utilisation du nonapeptide pat dans le traitement des maladies autoimmunes. |
| WO2021030689A2 (en) * | 2019-08-15 | 2021-02-18 | Cytolyf Therapeutics Llc | Zinc activated thymulin and methods of preparation and administration |
-
1981
- 1981-05-20 DK DK221681A patent/DK221681A/da not_active Application Discontinuation
- 1981-05-20 GR GR65000A patent/GR75636B/el unknown
- 1981-05-21 DE DE8181400807T patent/DE3166925D1/de not_active Expired
- 1981-05-21 IE IE113581A patent/IE51744B1/en not_active IP Right Cessation
- 1981-05-21 AU AU70905/81A patent/AU553640B2/en not_active Ceased
- 1981-05-21 CA CA000378037A patent/CA1170991A/en not_active Expired
- 1981-05-21 EP EP19810400807 patent/EP0041019B1/fr not_active Expired
- 1981-05-22 ES ES502911A patent/ES8306022A1/es not_active Expired
-
1982
- 1982-12-16 ES ES518298A patent/ES518298A0/es active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| DK221681A (da) | 1981-11-23 |
| DE3166925D1 (en) | 1984-12-06 |
| ES502911A0 (es) | 1983-05-01 |
| EP0041019A3 (en) | 1982-03-10 |
| EP0041019B1 (fr) | 1984-10-31 |
| ES8306022A1 (es) | 1983-05-01 |
| GR75636B (es) | 1984-08-02 |
| AU7090581A (en) | 1981-11-26 |
| IE51744B1 (en) | 1987-03-18 |
| EP0041019A2 (fr) | 1981-12-02 |
| IE811135L (en) | 1981-11-22 |
| AU553640B2 (en) | 1986-07-24 |
| CA1170991A (en) | 1984-07-17 |
| ES518298A0 (es) | 1984-12-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2966476D1 (en) | Azabicycloalkyl derivatives, a process for their preparation and pharmaceutical compositions containing them | |
| DE3261237D1 (en) | Sulphur-containing 5-hydroxy-alkanoic acid derivatives, their use as pharmaceutical preparations and process for their production | |
| DE3366932D1 (en) | New derivatives of biliary acids, process for the production thereof and pharmaceutical compositions containing the same | |
| EP0279149A3 (en) | Benzimidazole derivatives, process for their production and a pharmaceutical composition containing the same | |
| ZA792284B (en) | Structural analogs of natural phosphatides processes for their preparation,and pharmaceutical preparations thereof | |
| GB1544647A (en) | 2-piperidinoalkyl-1-benzofurans-1,4-benzodioxans and 1,4-benzoxathians process for their manufacture and pharmaceutical preparations containing them | |
| AU8514875A (en) | new 2, 3-DIHYDRO-1-BENZOTHIEPIN-4-CARBOXAMIDES PROCESS FOR THEIR MANUFACTURE AND PHARMACEUTICAL PREPARATIONS CONTAINING THEM | |
| GB2011900A (en) | N'-substituted -aminoalkanoyl- -aminoalkanoic acids their use and process for their production as well as pharmaceutical products containing these compounds | |
| DE3161611D1 (en) | Novel pyridinecarboxamide derivatives, a process for the preparation thereof, the use of said derivatives and a pharmaceutical composition containing same | |
| ES8501628A1 (es) | Procedimiento para la fabricacion de nuevos productos a partir del factor timico del suero, de sus analogos y derivados. | |
| DE3462852D1 (en) | Medicament preparation for external use comprising adenosin for the treatment of herpes | |
| DE2861593D1 (en) | Peptides, pharmaceutical compositions containing the peptides and a process for the preparation of the peptides | |
| DE3064499D1 (en) | Cyclic hexapeptide somatostatin analogs, process for their preparation and pharmaceutical compositions containing them | |
| ZA848303B (en) | 1,2-dithiolan derivatives,process for their production,pharmaceutical compositions containing them and their use | |
| ZA793100B (en) | New acetylene derivatives of androst-4-ene,process for preparing them,their use as a medicament and the pharmaceutical compositions containing them | |
| ZA849611B (en) | New 1,3-dioxolanyl derivatives,a process for their preparation,their use and pharmaceutical preparations containing these compounds | |
| IL88342A (en) | Derivatives of cysteine, process for their preparation and pharmaceutical compositions containing them | |
| ZA8103409D (en) | A process for the manufacture of novel benzazole derivatives,pharmaceutical preparations containing these derivatives,and their use | |
| ZA793967B (en) | New acetylene derivatives of androst-4-ene,process for preparing them,their use as medicaments and the pharmaceutical compositions containing them | |
| ZA757368B (en) | New 7,7-diphenyl-hexahydro-1,4-oxazepines,process for their manufacture and pharmaceutical preparations containing them | |
| DE2861570D1 (en) | 17 alpha-aryl or 17 alpha-heteroaryl steroids, process for their preparation, their use as medicines and pharmaceutical compositions containing them | |
| JPS646214A (en) | Remedy for ulcerative colonopathy | |
| ZA79365B (en) | Novel azathianaphthalene derivatives,process for their manufacture,pharmaceutical preparations containing them and their use | |
| IL49208A (en) | 13,14-dehydro-16-fluoro prostanoic acid derivatives of the f2,a2 and e2 series,process for their preparation and pharmaceutical compositions containing same | |
| IL48208A (en) | L -fluoro-21-hydroxy-16 -methyl- 1,4,8-pregnatriene derivatives,process for their preparation and pharmaceutical compositions containing them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD1A | Patent lapsed |
Effective date: 19970303 |